Complete response to dupilumab in a patient with chronic spontaneous urticaria who did not tolerate omalizumab

• Changhua Zhu, MD,
• Jie Shen Fok, MD,
• Lihang Lin, MD,
• Huichun Su, MD,
• Marcus Maurer, MD

Affiliations

Changhua Zhu, MD

Department of Dermatology, Fujian Medical University Union Hospital, Fuzhou, China

Jie Shen Fok, MD

Department of Respiratory Medicine and General Medicine, Box Hill Hospital, Eastern Health, Victoria, Australia; Allergy/Immunology, Monash Medical Centre, Monash Health, Victoria, Australia

Lihang Lin, MD

Department of Dermatology, Fujian Medical University Union Hospital, Fuzhou, China; Correspondence to: Lihang Lin, MD

Huichun Su, MD

Department of Dermatology, Fujian Medical University Union Hospital, Fuzhou, China; Huichun Su, MD, Department of Dermatology, Fujian Medical University Union Hospital, Xianquan Road 29, Fuzhou, Fujian 350001, China.

Marcus Maurer, MD

Institute of Allergology, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany; Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Allergology and Immunology, Berlin, Germany